Fertility testing measures specific, limited things: whether ovulation is happening, whether tubes are open, how the uterus looks, how ovaries respond to stimulation hormones, and — in a male partner — sperm parameters. What it cannot do is predict whether or when you will conceive naturally. A 2017 study in JAMA following more than 750 women aged 30 to 44 without a history of infertility found that anti-Müllerian hormone (AMH) levels were not significantly associated with the ability to conceive during a year of trying.
This article publishes information, not medical advice. It explains what each standard test measures, what its evidence supports, and where its limits are, so a fertility conversation starts from what the numbers genuinely mean. Decisions about your own care belong with you and your clinician.
When is fertility testing recommended?
The standard timing, per ACOG and the American Society for Reproductive Medicine, is an evaluation after 12 months of regular, unprotected intercourse without conception for people under 35, and after 6 months for those 35 or older. Earlier evaluation is reasonable with known factors — irregular cycles, endometriosis, prior pelvic surgery, cancer treatment — or with clear symptoms. The timelines exist because conception is not immediate even for fertile couples: per NICHD, among couples where the woman is under 30 and healthy, conception within three months is far from universal.
What does the standard work-up include?
A basic fertility evaluation, described in ASRM guidance, covers both partners and typically includes:
- Cycle and ovulation history. Regular cycles roughly every 21 to 35 days suggest ovulation is occurring; the pattern is itself diagnostic information.
- Ovulation markers. A progesterone blood test in the mid-luteal phase — about a week before an expected period — can confirm that ovulation occurred, per ACOG guidance.
- Ovarian reserve tests. AMH (a hormone produced by small ovarian follicles), follicle-stimulating hormone (FSH) with estradiol early in the cycle, and antral follicle count — the number of small resting follicles visible on ultrasound.
- Tubal patency. A hysterosalpingogram, an X-ray study in which contrast dye is passed through the cervix to show whether the fallopian tubes are open.
- Uterine assessment. Ultrasound, and in some cases sonohysterography or other imaging, to identify polyps, fibroids, or structural issues.
- Semen analysis. Per NICHD, male factors contribute to roughly one-third of infertility cases, female factors to roughly one-third, and the remainder involve both partners or remain unexplained — which is why testing both is standard.
- Screening labs. Thyroid function and prolactin, because both affect ovulation and are treatable.
What does "ovarian reserve" actually mean?
Ovarian reserve is an estimate of the number of remaining eggs, inferred from AMH, FSH, and antral follicle count. Three facts frame what these numbers can and cannot tell you, per ASRM's committee opinion on diagnostic evaluation of ovarian reserve (2020, reaffirming its 2015 position).
- These tests predict ovarian response to fertility medications — how many eggs a stimulated IVF cycle might yield — and that predictive role is well documented.
- They do not predict natural conception reliably. The 2017 JAMA study by Steiner and colleagues is the clearest single datapoint: among women trying to conceive without infertility diagnoses, low AMH did not translate into measurably lower conception over 12 months.
- They do not measure egg quality, which relates mostly to age through chromosome error rates in eggs, and which no blood test currently assesses.
A low result is information about a bell curve, not a deadline. Interpretation belongs in a clinical context — a single AMH value without the rest of the work-up, or without knowing why it was drawn, tells very little.
Why is the semen analysis part of a fertility work-up?
Because the contribution of male factors is too large to skip. NICHD's summary — roughly one-third male, one-third female, one-third both or unexplained — reflects decades of evaluation data, and ASRM guidance treats semen analysis as a first-line test for any couple's evaluation. It is also among the least invasive and least expensive tests involved, which makes the historical pattern of testing women exhaustively first both inefficient and unfair. Modern practice starts with both partners.
Related stories: Fibroid Treatment Options, Compared · Egg Freezing: What the Process Involves.
What can fertility testing not tell you?
Several things deserve explicit saying, because direct-to-consumer marketing often blurs them. Testing cannot predict whether you will conceive without assistance, or how quickly. An AMH number cannot tell you your "fertility age" in any validated sense — ASRM's guidance is explicit that ovarian reserve testing should not be used to reassure or dissuade people who are not currently seeking care for infertility. And no test guarantees that treatment will succeed; even with a full work-up, a share of infertility remains unexplained, per NICHD, meaning no cause is identified even after complete evaluation.
What happens after the tests?
Results are grouped into categories that map to treatments described in ASRM and ACOG guidance: ovulatory problems, addressed with medications that induce ovulation; tubal or uterine problems, addressed surgically in selected cases or with in vitro fertilization, which bypasses the tubes; male-factor findings, addressed with urologic evaluation and, where appropriate, IVF with intracytoplasmic sperm injection; and unexplained infertility, where options include timed intercourse, intrauterine insemination, and IVF, discussed with expected results that vary by age and circumstance. No outcome is promised by any path — the testing exists to sort possibilities, not to certify success.
When to talk to a clinician
Consider starting the conversation, per ACOG guidance, if you have tried to conceive for 12 months without success under 35, or 6 months at 35 or older; if your cycles are irregular, absent, or widely spaced; if you have known endometriosis, prior ectopic pregnancy, or pelvic surgery; if you have had cancer treatment; or if you simply want a baseline conversation before trying. Baseline conversations are legitimate uses of an appointment — they do not obligate you to treatment.
A fertility work-up answers a small set of specific questions well. Everything else it is sometimes advertised to answer — your timeline, your odds, your story — is outside what the evidence supports.
Frequently asked questions
Can an AMH test tell me if I can get pregnant? No. Per a 2017 JAMA study of women without infertility, AMH was not significantly associated with conception during a year of trying, and ASRM's guidance states ovarian reserve tests should not be used to predict natural fertility. AMH's documented value is predicting how ovaries respond to stimulation medications in IVF — a different question entirely.
Does a high FSH level mean menopause is near? Not on its own. FSH rises as ovarian reserve declines, and interpretation depends on cycle phase, age, and repeated measurements, per ASRM guidance. A single elevated value early in a cycle is a data point about ovarian response, not a menopause prediction; diagnosis of menopause rests on twelve months without a period, per ACOG.
Is a hysterosalpingogram painful? Discomfort varies. Many people report cramping during the dye passage that resolves quickly; some report little sensation at all. Clinicians often suggest taking a standard pain reliever beforehand, per routine practice described in ACOG patient materials. It is a short outpatient procedure, and results inform whether tubes are open — a question no blood test can answer.
Do I need fertility testing if my cycles are perfectly regular? Regular cycles suggest ovulation, which is genuinely useful information, but they rule out only one category of causes. Tubal factors, uterine factors, and male factors do not change cycle regularity. That is why the standard work-up after the recommended timeframes covers both partners and several systems, per ASRM guidance, regardless of how regular a cycle is.
Is unexplained infertility a real diagnosis? Yes — it is the standard term for infertility in which the standard evaluation, completed on both partners, identifies no cause, per NICHD. It is common, it is not a failure of the work-up, and it has a defined set of treatment pathways with studied results. The label reflects the honest limit of current testing, not an absence of anything wrong.